Nabumetone Should Be Discontinued for Headache Treatment
You should stop taking nabumetone for headache immediately, as there is no evidence supporting its use for this indication, and continuing it exposes you to unnecessary risks without benefit. 1
Why Nabumetone Is Not Appropriate for Headache
Nabumetone is an NSAID approved for osteoarthritis and rheumatoid arthritis, not for headache treatment. The 2002 Annals of Internal Medicine guideline explicitly states: "There is no evidence for the use of ibuprofen or nabumetone in the prevention of migraine." 1 This means nabumetone has been studied and found to lack efficacy for headache conditions.
Recommended Alternatives for Headache Treatment
For Acute Migraine Treatment:
First-line options include: 2, 3
- Aspirin-acetaminophen-caffeine combination (strong evidence) 3
- Ibuprofen 400-800 mg 4, 3
- Naproxen sodium 275-550 mg 4, 3
- Aspirin 650-1,000 mg 4
For Moderate-to-Severe Migraine:
If NSAIDs fail, triptans (sumatriptan, rizatriptan, zolmitriptan) are recommended 2, 3
Critical Safety Concerns with Continued Nabumetone Use
Risk of Medication-Overuse Headache (MOH)
Using any NSAID more than twice weekly for headache can cause medication-overuse headache 2, 4, a condition where the medication itself perpetuates chronic daily headache. This is defined as headache occurring ≥15 days/month for >3 months due to regular overuse of acute headache medication 5. The treatment success rate for MOH is only 50-70%, with significant relapse rates 5.
Gastrointestinal Risks
While nabumetone has better GI tolerability than some NSAIDs 6, 7, the FDA label warns: 8
- Upper GI ulcers, bleeding, or perforation occur in approximately 1% of patients at 3-6 months and 2-4% at 1 year
- Risk increases with duration of use
- Can occur without warning symptoms
Monitor for: 8
- Epigastric pain, dyspepsia
- Black/tarry stools (melena) or blood in stool
- Vomiting blood (hematemesis)
- Unexplained anemia symptoms (fatigue, weakness)
Cardiovascular Risks
NSAIDs can cause: 8
- Increased blood pressure (mean increase 5 mm Hg) 9
- Increased risk of myocardial infarction and stroke
- Worsening of heart failure
- Fluid retention and edema
Monitor for: 8
- Chest pain, shortness of breath
- Weakness or slurred speech
- Unexplained weight gain or swelling
Renal and Hepatic Risks
- Renal toxicity can occur, especially with prolonged use
- Liver enzyme elevations occur in up to 15% of patients
- Rare cases of severe hepatic reactions including fatal fulminant hepatitis
Monitor for: 8
- Dark urine, pale stools
- Yellowing of skin/eyes (jaundice)
- Unusual fatigue, nausea, right upper abdominal pain
Serious Skin Reactions
- Stevens-Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN) can occur
- These are potentially fatal
Monitor for: 8
- Any new rash, blisters, or skin peeling
- Fever with rash
- Mouth sores
Immediate Action Plan
- Discontinue nabumetone - it provides no benefit for headache and only exposes you to risks
- Switch to evidence-based acute headache treatment as outlined above
- Limit acute headache medication use to no more than 2 days per week to prevent medication-overuse headache 2
- If you have headaches ≥4 days per month, discuss preventive therapy with your physician (options include propranolol, topiramate, or newer CGRP antagonists) 3, 10
Common Pitfall to Avoid
The most critical error would be continuing nabumetone simply because "it's an NSAID" - not all NSAIDs have evidence for headache treatment, and nabumetone specifically lacks this evidence 1. Using an ineffective medication exposes you to all the risks without therapeutic benefit, and may delay appropriate treatment while allowing headaches to become chronic.